Tamoxifen’s Impact on Lipid Profiles in Male Breast Cancer Patients: A Cohort Study
Reading Time: 3 minutes Introduction Breast cancer, though less common in men than in women, poses significant health challenges and necessitates tailored therapeutic approaches. Tamoxifen, a selective estrogen receptor modulator (SERM), is a cornerstone in the treatment of hormone receptor-positive breast cancer. While its efficacy in reducing cancer recurrence is well-documented, its effects on lipid profiles in male patients remain underexplored. This article delves into a comprehensive cohort study examining the impact of tamoxifen on lipid profiles in American males diagnosed with breast cancer, offering insights into its metabolic implications. Study Design and Methodology Our study encompassed a cohort of 150 American males diagnosed...


